These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 21034746

  • 1. Centchroman mediated apoptosis involves cross-talk between extrinsic/intrinsic pathways and oxidative regulation.
    Nigam M, Singh N, Ranjan V, Zaidi D, Sharma R, Nigam D, Gupta DK, Sundaram S, Balapure AK.
    Life Sci; 2010 Dec 18; 87(23-26):750-8. PubMed ID: 21034746
    [Abstract] [Full Text] [Related]

  • 2. Centchroman induces G0/G1 arrest and caspase-dependent apoptosis involving mitochondrial membrane depolarization in MCF-7 and MDA MB-231 human breast cancer cells.
    Nigam M, Ranjan V, Srivastava S, Sharma R, Balapure AK.
    Life Sci; 2008 Mar 12; 82(11-12):577-90. PubMed ID: 18279897
    [Abstract] [Full Text] [Related]

  • 3. PA-MSHA inhibits proliferation and induces apoptosis through the up-regulation and activation of caspases in the human breast cancer cell lines.
    Liu ZB, Hou YF, Min-Dong, Di GH, Wu J, Shen ZZ, Shao ZM.
    J Cell Biochem; 2009 Sep 01; 108(1):195-206. PubMed ID: 19562667
    [Abstract] [Full Text] [Related]

  • 4. HL-37, a novel anthracene derivative, induces Ca(2+)-mediated apoptosis in human breast cancer cells.
    Xie SQ, Zhang ZQ, Hu GQ, Xu M, Ji BS.
    Toxicology; 2008 Dec 05; 254(1-2):68-74. PubMed ID: 18948164
    [Abstract] [Full Text] [Related]

  • 5. Dietary isoflavone daidzein synergizes centchroman action via induction of apoptosis and inhibition of PI3K/Akt pathway in MCF-7/MDA MB-231 human breast cancer cells.
    Kaushik S, Shyam H, Sharma R, Balapure AK.
    Phytomedicine; 2018 Feb 01; 40():116-124. PubMed ID: 29496164
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells.
    Kumar R, Mandal M, Lipton A, Harvey H, Thompson CB.
    Clin Cancer Res; 1996 Jul 01; 2(7):1215-9. PubMed ID: 9816290
    [Abstract] [Full Text] [Related]

  • 7. Troglitazone enhances tamoxifen-induced growth inhibitory activity of MCF-7 cells.
    Yu HN, Noh EM, Lee YR, Roh SG, Song EK, Han MK, Lee YC, Shim IK, Lee SJ, Jung SH, Kim JS, Youn HJ.
    Biochem Biophys Res Commun; 2008 Dec 05; 377(1):242-7. PubMed ID: 18835379
    [Abstract] [Full Text] [Related]

  • 8. Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.
    Somers-Edgar TJ, Rosengren RJ.
    Anticancer Drugs; 2009 Jan 05; 20(1):33-40. PubMed ID: 18830129
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biological evaluation of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone as an anti-breast cancer agent.
    Kanaan YM, Das JR, Bakare O, Enwerem NM, Berhe S, Beyene D, Williams V, Zhou Y, Copeland RL.
    Anticancer Res; 2009 Jan 05; 29(1):191-9. PubMed ID: 19331150
    [Abstract] [Full Text] [Related]

  • 11. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S, Krishnan AV, Feldman D.
    Clin Cancer Res; 2000 Aug 05; 6(8):3371-9. PubMed ID: 10955825
    [Abstract] [Full Text] [Related]

  • 12. Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells.
    Choi EJ, Bae SM, Ahn WS.
    Arch Pharm Res; 2008 Oct 05; 31(10):1281-5. PubMed ID: 18958418
    [Abstract] [Full Text] [Related]

  • 13. Chalcone inhibits the proliferation of human breast cancer cell by blocking cell cycle progression and inducing apoptosis.
    Hsu YL, Kuo PL, Tzeng WS, Lin CC.
    Food Chem Toxicol; 2006 May 05; 44(5):704-13. PubMed ID: 16307839
    [Abstract] [Full Text] [Related]

  • 14. [Status of estrogen receptor affects the drug sensitivity of drug-resistant MCF-7/Adr human breast cancer cells to droloxifene and Adriamycin].
    Gao HD, Sun JZ, Bi DS, Ma R.
    Ai Zheng; 2003 Apr 05; 22(4):376-9. PubMed ID: 12703992
    [Abstract] [Full Text] [Related]

  • 15. Tamoxifen and TRAIL synergistically induce apoptosis in breast cancer cells.
    Lagadec C, Adriaenssens E, Toillon RA, Chopin V, Romon R, Van Coppenolle F, Hondermarck H, Le Bourhis X.
    Oncogene; 2008 Feb 28; 27(10):1472-7. PubMed ID: 17767197
    [Abstract] [Full Text] [Related]

  • 16. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
    Frankel LB, Lykkesfeldt AE, Hansen JB, Stenvang J.
    Breast Cancer Res Treat; 2007 Aug 28; 104(2):165-79. PubMed ID: 17061041
    [Abstract] [Full Text] [Related]

  • 17. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW, Li Y, Wang Z, Sarkar SH, Sarkar FH.
    Cancer Res; 2006 May 01; 66(9):4952-60. PubMed ID: 16651453
    [Abstract] [Full Text] [Related]

  • 18. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.
    Mandlekar S, Yu R, Tan TH, Kong AN.
    Cancer Res; 2000 Nov 01; 60(21):5995-6000. PubMed ID: 11085519
    [Abstract] [Full Text] [Related]

  • 19. Centchroman inhibits proliferation of head and neck cancer cells through the modulation of PI3K/mTOR pathway.
    Srivastava VK, Gara RK, Bhatt ML, Sahu DP, Mishra DP.
    Biochem Biophys Res Commun; 2011 Jan 07; 404(1):40-5. PubMed ID: 21094138
    [Abstract] [Full Text] [Related]

  • 20. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K, Su J, Trovitch PB.
    J Pharm Pharmacol; 2003 Aug 07; 55(8):1135-41. PubMed ID: 12956904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.